Picture of Belluscura logo

BELL — Belluscura Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-2.29%
3m-21.6%
6m-25.3%
1yr+42.22%
Volume Change (%)
10d/3m-8.89%
Price vs... (%)
52w High-46.71%
50d MA-10.95%
200d MA-21.28%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-20.81%
Return on Equity-35.54%
Operating Margin-1233.98%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Belluscura EPS forecast chart

Profile Summary

Belluscura PLC is a United Kingdom-based medical device company. The Company is focused on developing oxygen enrichment technology to broad industries and therapies. Its product X-PLOR, is a modular portable oxygen concentrator. It is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The device can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing the medical devices for treating people who are suffering from chronic lung diseases, such as the chronic obstructive pulmonary disease (COPD), respiratory distress caused by coronavirus disease (COVID-19), cardiac cases, and other respiratory disorders.

Directors

    Last Annual
    December 31st, 2021
    Last Interim
    December 31st, 2021
    Incorporated
    December 10th, 2015
    Public Since
    January 1st, 1970
    No. of Employees
    11
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    114,168,777
    Blurred out image of a map
    Address
    15 Fetter Lane, LONDON, EC4A 1BW
    Web
    https://www.belluscura.com/
    Phone
    +1 2143968313
    Auditors
    Jeffreys Henry Audit Limited

    BELL Share Price Performance

    Similar to BELL

    Picture of Abingdon Health logo

    Abingdon Health

    gb flag iconLondon Stock Exchange

    Picture of Advanced Medical Solutions logo

    Advanced Medical Solutions

    gb flag iconLondon Stock Exchange

    Picture of Advanced Oncotherapy logo

    Advanced Oncotherapy

    gb flag iconLondon Stock Exchange

    Picture of Angle logo

    Angle

    gb flag iconLondon Stock Exchange

    Picture of Aptamer logo

    Aptamer

    gb flag iconLondon Stock Exchange

    FAQ

    Or unlock with your email

    Or unlock with your email